Daiichi Sankyo

Daiichi Sankyo — Acquisitions

Every M&A deal made by Daiichi Sankyo, sorted by date.

📍 Tokyo Total deals 5 Total value $5.9B View company profile →
5
Total deals
$5.9B
Total value
$2.0B
Avg deal
$4.6B
Largest
Acquisition activity by year
Deals announced per year
08 11 14 15
# Acquired Date Type Status Price
1
I
Im Co., Ltd.
Im Co., Ltd is manufactures and sells cosmetics and over-the-counter drugs.
2015-10-08 Acquisition Complete Deal →
2
Ambit Biosciences
Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase i…
2014-09-29 Acquisition Complete $410.0M Deal →
3
Plexxikon
Plexxikon is a engages in the discovery and development of small molecule pharma…
2011-02-28 Acquisition Complete $935.0M Deal →
4
Ranbaxy Laboratories
Ranbaxy Laboratories is a pharmaceutical company that manufactures and markets a…
2008-11-01 Acquisition Complete $4.6B Deal →
5
U3 Pharma
U3 Pharma is a pharmaceutical company that focuses in targeted cancer drug devel…
2008-05-21 Acquisition Complete Deal →